The influence of genetic polymorphisms of CYP3A on the pharmacokinetic variation and clinical outcomes of tacrolimus in a cohort of patients / Mohd Rahimi Muda
The complexity of determining the variability in tacrolimus pharmacokinetics parameter among organ transplant patients and its narrow therapeutic window characteristics necessitates proper drug monitoring in order to ensure the level is maintained within therapeutic range. Many studies have reported...
Main Author: | Muda, Mohd Rahimi |
---|---|
Format: | Thesis |
Language: | English |
Published: |
2014
|
Subjects: | |
Online Access: | http://ir.uitm.edu.my/id/eprint/15160/ http://ir.uitm.edu.my/id/eprint/15160/1/TM_MOHD%20RAHIMI%20MUDA%20PH%2014_5.pdf |
Similar Items
-
Genetic Polymorphism of CYP2D6 and MDR1 in breast cancer patients treated with tamoxifen
by: Mohamad, NI, et al.
Published: (2010) -
CYP2C9 polymorphism: prevalence in healthy and warfarin-treated Malay and Chinese in Malaysia
by: Ngow, Harris Abdullah, et al.
Published: (2009) -
Plasma & subcutaneous tissue pharmacokinetics of piperacillin in a large cohort of critically ill patients with sepsis
by: Abdul Aziz, Mohd. Hafiz, et al.
Published: (2014) -
Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease
by: Abd. Rahman, Nurul Azrin, et al.
Published: (2013) -
Investigation of the riddle of sulfathiazole polymorphism
by: Abu Bakar, Mohd Rushdi, et al.
Published: (2011)